Inside informationEnglish
Ipsen update on Phase II FALKON trial in patients with ultra-rare bone disease, fibrodysplasia ossificans progressiva (FOP)
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Ipsen SA
- Filed
- 19/12/2025, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 115778_20251219